Terms: = Lymphoma AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Treatment
19 results:
1. Synchronous T-lymphoblastic lymphoma and neuroblastoma in a 3-yr-old with novel germline
Tibout P; Livingston J; Kanwar N; Yuki KE; Shlien A; Ngan B; Irwin MS; Morgenstern DA; Hitzler J; Villani A; Cohen-Gogo S
Cold Spring Harb Mol Case Stud; 2023 Dec; 9(4):. PubMed ID: 37932047
[TBL] [Abstract] [Full Text] [Related]
2. Tazemetostat for tumors harboring SMARCB1/smarca4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
Chi SN; Yi JS; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey BD; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga JC; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
J Natl Cancer Inst; 2023 Nov; 115(11):1355-1363. PubMed ID: 37228094
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib.
Miao E; Eichholz JE; Lebow ES; Flynn J; Zhang Z; Walch H; Hubbeling H; Beal K; Moss NS; Yu KK; Meng A; Kelly DW; Gomez DR; Li BT; Rimner A; Schultz N; Drilon A; Imber BS; Pike LRG
Lung Cancer; 2023 Apr; 178():57-65. PubMed ID: 36780766
[TBL] [Abstract] [Full Text] [Related]
4. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
[No Abstract] [Full Text] [Related]
5. Differential prognostic effect of systemic inflammation in patients with non-small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial.
Cortellini A; Ricciuti B; Borghaei H; Naqash AR; D'Alessio A; Fulgenzi CAM; Addeo A; Banna GL; Pinato DJ
Cancer; 2022 Aug; 128(16):3067-3079. PubMed ID: 35727053
[TBL] [Abstract] [Full Text] [Related]
6. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Zhao S; Kanagal-Shamanna R; Navsaria L; Ok CY; Zhang S; Nomie K; Han G; Hao D; Hill HA; Jiang C; Yao Y; Nastoupil L; Westin J; Fayad L; Nair R; Steiner R; Ahmed S; Samaniego F; Iyer SP; Oriabure O; Chen W; Song X; Zhang J; Badillo M; Moghrabi O; Aranda J; Tang G; Yin CC; Patel K; Medeiros LJ; Li S; Vega F; Thirumurthi S; Xu G; Neelapu S; Flowers CR; Romaguera J; Fowler N; Wang L; Wang ML; Jain P
Am J Hematol; 2020 Jun; 95(6):623-629. PubMed ID: 32239765
[TBL] [Abstract] [Full Text] [Related]
8. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
9. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
Jain P; Wang M
Am J Hematol; 2019 Jun; 94(6):710-725. PubMed ID: 30963600
[TBL] [Abstract] [Full Text] [Related]
10. Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Italiano A; Soria JC; Toulmonde M; Michot JM; Lucchesi C; Varga A; Coindre JM; Blakemore SJ; Clawson A; Suttle B; McDonald AA; Woodruff M; Ribich S; Hedrick E; Keilhack H; Thomson B; Owa T; Copeland RA; Ho PTC; Ribrag V
Lancet Oncol; 2018 May; 19(5):649-659. PubMed ID: 29650362
[TBL] [Abstract] [Full Text] [Related]
11. [Oridonin inhibits proliferation of Jurkat cells via the down-regulation of brg1].
Ye ZZ; Xue FL; Ding WP; Kong X; Shen YN
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Nov; 19(11):1208-1212. PubMed ID: 29132471
[TBL] [Abstract] [Full Text] [Related]
12. brg1 regulation by miR-155 in human leukemia and lymphoma cell lines.
Cuadros M; Sánchez-Martín V; Herrera A; Baliñas C; Martín-Padrón J; Boyero L; Peinado P; Medina PP
Clin Transl Oncol; 2017 Aug; 19(8):1010-1017. PubMed ID: 28251496
[TBL] [Abstract] [Full Text] [Related]
13. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
[TBL] [Abstract] [Full Text] [Related]
14. Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
Katoh M
Epigenomics; 2016 Feb; 8(2):285-305. PubMed ID: 26411517
[TBL] [Abstract] [Full Text] [Related]
15. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
[TBL] [Abstract] [Full Text] [Related]
16. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract] [Full Text] [Related]
17. New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing.
Greenough A; Dave SS
Curr Opin Hematol; 2014 Jul; 21(4):326-32. PubMed ID: 24867287
[TBL] [Abstract] [Full Text] [Related]
18. MicroRNA-21 targets tumor suppressor genes ANP32A and smarca4.
Schramedei K; Mörbt N; Pfeifer G; Läuter J; Rosolowski M; Tomm JM; von Bergen M; Horn F; Brocke-Heidrich K
Oncogene; 2011 Jun; 30(26):2975-85. PubMed ID: 21317927
[TBL] [Abstract] [Full Text] [Related]
19. The SWI/SNF chromatin-remodeling complex and glucocorticoid resistance in acute lymphoblastic leukemia.
Pottier N; Yang W; Assem M; Panetta JC; Pei D; Paugh SW; Cheng C; Den Boer ML; Relling MV; Pieters R; Evans WE; Cheok MH
J Natl Cancer Inst; 2008 Dec; 100(24):1792-803. PubMed ID: 19066270
[TBL] [Abstract] [Full Text] [Related]
